| SECTOR | INDUSTRY |
| Health Care | Health Care Equipment & Supplies |
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
Jenna Brashear
Rosalio Madrigal
Cynthia McLaughlin
Rosalio Madrigal
Rosalio Madrigal
| Share Statistics | KMTS | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $1,616.5 | $371.1 | 52% |
|
| Shares Out (Mil) | 58.6 | 41.2 | 51% |
|
| Institutional Ownership | 98.2% | 82.7% | 77% |
|
| Float (Mil) | 33.7 | 35.5 | 38% |
|
| Beta | na | 0.85 | na |
|
| Avg Daily Volume (000s) | 529 | 336 | 57% |
|
| Price Change (52-week) |
10.3% | 64.5% | 60% |
|
| Growth | KMTS | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | na | 11.8% | na |
|
| Net Income (5yr) | (34.9%) | (5.7%) | 11% |
|
| EPS (5yr) | 61.3% | 10.2% | 96 |
|
| Dividends (5yr) | na | 0.0% | 0% |
|
| Cash Flow (5yr) | 1.2% | (15.5%) | 65% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 2 | 2 | 2 | |
| Current EPS | ($0.605) | ($2.450) | ($2.055) | |
| Month Ago EPS | ($0.615) | ($2.305) | ($2.020) | |
| # Rev Up | 0 | 1 | 1 | |
| # Rev Down | 1 | 3 | 2 | |
| Three Months Ago EPS | ($0.545) | ($2.140) | ($1.410) | |
| Year/Year Chg | (19.7%) | 0.9% | (30.0%) | |
| Financials | KMTS | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $107 | $119 | 27% |
|
| Net Income (TTM) (Mil) | ($150) | ($9) | 9% |
|
| EPS (TTM) | ($2.676) | ($0.400) | 12% |
|
| Operating Cash Flow (TTM) (Mil) | ($88) | ($3) | 7% |
|
| Net Cash Flow (TTM) (Mil) | ($133) | $1 | 12% |
|
| Long-Term Debt (Q1) (Mil) | $76 | $23 | 42% |
|
| Enterprise Value (Q1) (Mil) | $1,312 | $376 | 44% |
|
| Valuation | KMTS | Industry Median |
Percentile (All Stocks) |
|
| P/B | 7.24 | 2.78 | 86% |
|
| P/E | na | 25.5 | na |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 1.5 | na |
|
| Ratios | KMTS | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 53.9% | 59.0% | 66% |
|
| Net Margin | (140.4%) | (6.9%) | 6% |
|
| ROA | (48.8%) | (12.3%) | 12% |
|
| ROE | (73.7%) | (11.1%) | 12% |
|
| Liabilities to Assets | 36.0% | 46.5% | 27% |
|
| F-Score | 2 | 4 | 7% |
|
Kestra Medical Technologies, Ltd. did not pass any screens on 9/25/2026.
Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.
Ⓒ 2026 American Association of Individual Investors
